Botswana’s pharmaceutical sector presents diverse opportunities amidst complex health challenges like HIV/AIDS, malaria, tuberculosis, and strains due to COVID-19. To build resilience and self-reliance in healthcare, the government emphasizes local pharmaceutical manufacturing. Three local firms repackaging medicines and a veterinary vaccine manufacturer cater to regional demands, with great opportunities for collaboration with international firms.

Opportunities are ripe in biopharmaceutical products, with the Botswana Vaccine Institute (BVI) leading in veterinary vaccines and aiming to develop human vaccines. The mining sector also offers potential in pharmaceutical-grade raw materials such as sodium chloride and sodium carbonate. Conventional medicines like antiretrovirals and cardiovascular drugs, and the development of herbal medicines, offer further investment avenues.

Strategic collaboration, innovation, infrastructure development, and regulatory enhancement can make Botswana a significant player in the African pharmaceutical landscape, fostering economic growth, job creation, and healthcare robustness.

To gain a comprehensive overview of opportunities in Botswana’s life science, health and pharmaceutical sector and gain insights on how you can benefit from untapped opportunities, download the sector profile.